ADIPOCYTE DYSFUNCTION IN AN IPSC MODEL OF FAMILIAL PARTIAL LIPODYSTROPHY DUE TO MUTATIONS IN LMNA

被引：0
|
作者：
Alvarez, Aluet Borrego [1 ]
Liu, Katie [1 ]
Gobble, McKinlee [1 ]
Grupe, Michael [1 ]
Buchser, William [1 ]
Baldridge, Dustin [1 ]
Stone, Stephen [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2024年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6852
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [1] Myopathy in patients with familial partial lipodystrophy due to LMNA mutations
    Spuler, S
    Kalbhenn, T
    Schmidt, HJ
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 591 - 591
  • [2] A case of familial partial lipodystrophy due to a rare homozygous LMNA mutation
    De Buitleir, Ciara
    Newman, Christine
    Griffin, Tomas
    O'Shea, Paula
    O'Brien, Timothy
    Liew, Aaron
    Dinneen, Sean
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S180 - S180
  • [3] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    D. B. Savage
    I. McFarlane
    I. Barroso
    M. A. Soos
    A. Powlson
    E. L. Thomas
    J. D. Bell
    I. Scobie
    P. E. Belchetz
    W. F. Kelly
    D. J. Halsall
    A. J. Schafer
    S. O’Rahilly
    Diabetologia, 2004, 47 : 753 - 756
  • [4] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    Savage, DB
    Soos, MA
    Powlson, A
    O'Rahilly, S
    McFarlane, I
    Halsall, DJ
    Barroso, I
    Thomas, EL
    Bell, JD
    Scobie, I
    Belchetz, PE
    Kelly, WF
    Schafer, AJ
    DIABETOLOGIA, 2004, 47 (04) : 753 - 756
  • [5] Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
    Owen, KR
    Donohoe, M
    Ellard, S
    Hattersley, AT
    DIABETIC MEDICINE, 2003, 20 (10) : 823 - 827
  • [6] Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
    Vasandani, Chandna
    Li, Xilong
    Sekizkardes, Hilal
    Brown, Rebecca J.
    Garg, Abhimanyu
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (12)
  • [7] LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A
    Tu, Yiping
    Sanchez-Iglesias, Sofia
    Araujo-Vilar, David
    Fong, Loren G.
    Young, Stephen G.
    NUCLEUS, 2016, 7 (05) : 512 - 521
  • [8] Cosegregation of Focal Segmental Glomerulosclerosis in a Family with Familial Partial Lipodystrophy due to a Mutation in LMNA
    Thong, Kah Mean
    Xu, Yaoxian
    Cook, Jackie
    Takou, Anna
    Wagner, Bart
    Kawar, Bisher
    Ong, Albert C. M.
    NEPHRON CLINICAL PRACTICE, 2013, 124 (1-2): : 31 - 37
  • [9] Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases
    Morguetti, Maria Julia
    Neves, Precil Diego Miranda de Menezes
    Korkes, Ilana
    Padilha, Wallace Stwart Carvalho
    Jorge, Lecticia Barbosa
    Watanabe, Andreia
    Watanabe, Elieser Hitoshi
    Malheiros, Denise Maria Avancini Costa
    Noronha, Irene de Lourdes
    Dib, Sergio Atala
    Onuchic, Luiz Fernando
    Moises, Regina S.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [10] Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants
    Sekizkardes, Hilal
    Cochran, Elaine
    Malandrino, Noemi
    Garg, Abhimanyu
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08): : 3068 - 3076
12345